Add Axona as part of Alzheimer’s disease management

Adding medical foods is a key part of comprehensive Alzheimer’s disease management

Adding Axona to Alzheimer's disease management may address a specific nutritional deficiency not addressed by FDA-approved Alzheimer's treatments.1

Unlike the FDA-approved drug classes called acetylcholinesterase inhibitors (AChEIs) and N-methyl-D-aspartic acid (NMDA) receptor antagonists, Axona provides medium-chain triglycerides to the body that can be metabolized into ketone bodies as an alternative fuel source for the brain.1,2

Interactive
extra energyreduced exitoxbetter communication

MEDICAL FOOD – AXONA

Extra energy1,2

Axona provides medium-chain triglycerides to the body that can be metabolized into ketone bodies, which may be utilized by the brain as an alternative source of fuel.

DRUG TREATMENT

Reduced excitotoxicity3

N-methyl-D-aspartic acid (NMDA) receptor antagonists protect neurons from the harmful effects of excessive glutamate activity in the brain.

Better communication3

Acetylcholinesterase inhibitors (AChEIs) slow the breakdown of acetylcholine (ACh), a key neurotransmitter involved in learning and memory.

Axona may be used concurrently with Alzheimer’s drug treatments1,4

  • Approximately 80% of Axona clinical trial participants were taking at least one prescription of Alzheimer’s disease medicine
  • Axona may be taken alone or with Alzheimer’s disease drug treatments, including AChEIs and NMDA receptor antagonists

Add Axona. Add what’s been missing from Alzheimer’s disease therapy.